Department of Molecular and Cellular Physiology, Louisiana Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130, USA.
Mutagenesis. 2013 May;28(3):357-66. doi: 10.1093/mutage/get009. Epub 2013 Feb 28.
Clustered DNA lesions are defined as ≥2 damage events within 20 bp. Oxidised bases, abasic (AP) sites, single-strand breaks and double-strand breaks (DSBs) exist in radiation-induced clusters, and these lesions are more difficult to repair and can be more mutagenic than single lesions. Understanding clustered lesion repair is therefore important for the design of complementary treatments to enhance radiotherapy. Non-DSB-clustered lesions consisting of opposing AP sites can be converted to DSBs by base excision repair, and non-homologous end-joining (NHEJ) plays a role in repairing these DSBs. Artemis is an endonuclease that removes blocking groups from DSB termini during NHEJ. Hence, we hypothesised that Artemis plays a role in the processing of DSBs or complex DSBs generated from non-DSB-clustered lesions. We examined the repair of clusters containing two or three lesions in wild-type (WT) or Artemis-deficient (ART(-/-)) mouse fibroblasts using a reporter plasmid. Each cluster contained two opposing tetrahydrofurans (an AP site analogue), which AP endonuclease can convert to a DSB with blocked 5' termini. Loss of Artemis did not decrease plasmid survival, but did result in more mutagenic repair with plasmids containing larger deletions. This increase in deletions did not occur with ClaI-linearised plasmid. Since Mre11 has been implicated in deletional NHEJ, we used small interfering RNA to reduce Mre11 in WT and ART(-/-) cells, but decreasing Mre11 did not change the size of deletions in the repair products. This work implicates Artemis in limiting the deletions introduced during repair of 5'-blocked termini DSBs generated from non-DSB-clustered lesions. Decreasing repair accuracy without decreasing repair capacity could result in mutated cells surviving irradiation. Inhibiting Artemis in normal cells could promote carcinogenesis, while in tumour cells enhanced mutagenic repair following irradiation could promote tumour recurrence.
簇状 DNA 损伤被定义为在 20 个碱基对内发生≥2 个损伤事件。氧化碱基、无碱基(AP)位点、单链断裂和双链断裂(DSB)存在于辐射诱导的簇中,这些损伤更难修复,并且比单个损伤更具突变性。因此,了解簇状损伤修复对于设计互补治疗方法以增强放射治疗至关重要。由相反的 AP 位点组成的非 DSB 簇状损伤可以通过碱基切除修复转化为 DSB,非同源末端连接(NHEJ)在修复这些 DSB 中发挥作用。Artemis 是一种内切酶,可在 NHEJ 过程中从 DSB 末端去除阻断基团。因此,我们假设 Artemis 在 DSB 或非 DSB 簇状损伤产生的复杂 DSB 的处理中发挥作用。我们使用报告质粒检查了野生型(WT)或 Artemis 缺陷型(ART(-/-))小鼠成纤维细胞中包含两个或三个损伤的簇的修复。每个簇包含两个相反的四氢呋喃(AP 位点类似物),AP 内切酶可以将其转化为具有 5' 末端受阻的 DSB。Artemis 的缺失不会降低质粒的存活率,但会导致含有较大缺失的质粒产生更多的诱变修复。这种缺失的增加不会发生在 ClaI 线性化的质粒上。由于 Mre11 已被牵连在缺失性 NHEJ 中,我们使用小干扰 RNA 降低 WT 和 ART(-/-)细胞中的 Mre11,但降低 Mre11 不会改变修复产物中缺失的大小。这项工作表明 Artemis 限制了从非 DSB 簇状损伤产生的 5' 端受阻的 DSB 修复过程中引入的缺失。在不降低修复能力的情况下降低修复准确性可能会导致突变细胞在照射后存活。在正常细胞中抑制 Artemis 可能会促进癌变,而在肿瘤细胞中,照射后增强的诱变修复可能会促进肿瘤复发。